- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02289170
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
9 novembre 2014 mis à jour par: Eun Jung Kim
A Randomized, Double-blind, Multicenter, Parallel Designed Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) in Patients With Chronic Low Back Pain
The purpose of this study is to verify the efficacy and safety of heating and cooling combination therapeutic device (OCH-S100) for patients with chronic low back pain (LBP).
Aperçu de l'étude
Statut
Inconnue
Les conditions
Intervention / Traitement
Description détaillée
The investigators targeted the patients with chronic LBP.
After treatment in 2 groups - real heating and cooling combination treatment and sham heating and cooling combination treatment - the investigators will compare the effects of pain relief and improvement in disability and range of motion of lumbar region.
So the investigators will confirm the efficacy of heating and cooling combination therapy, and further the best treatment method.
In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.
Type d'étude
Interventionnel
Inscription (Anticipé)
80
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Gyeonggi-do
-
Seongnam, Gyeonggi-do, Corée, République de, 463-865
- Recrutement
- Donnguk University Oriental Medical Hospital
-
Contact:
- Eun Jung Kim, Ph.D.
- Numéro de téléphone: 82-31-710-3751
- E-mail: hanijjung@naver.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
20 ans à 75 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- At least 20 years of age, but below 75 years of age
- Low back pain in the last 3 months or more
- Low back pain rated over 40 mm on a 100 mm Visual Analog Scale (VAS)
- Those who are reliable and willing to cooperate in this test, and obey the restrictions for the treatment period.
- An understanding of the objectives, methods and efficacy of the clinical trial, and willingness in completing the consent form.
Exclusion Criteria:
- Trauma to or surgery on the lumbar region within 6 months prior to enrollment
- Low back pain accompanied by sciatica
- Systematic disease, and severe dysfunction due to the medical illness (e.g. cancer, infection, etc.)
- A history of medication, oriental medical treatment, physiotherapy for treating low back pain within the last 4 weeks
- Neurological disease, such as topical or whole body hypoesthesia in temperature sensation (e.g. stroke, peripheral neuropathy, etc.)
- Hypersensitivity in heating and cooling stimulation
- Pregnant and lactating women
- Participate in the other clinical trials within the last 3 months or after enroll this trial
- When researchers evaluate that it is not appropriate to participate in this clinical test
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Heating and cooling combination therapy
The patients in this group received heating and cooling combination therapy by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience.
Doctor press 8 acupuncture points which is treated in LBP patients and select the most painful 2 acupuncture points.
Device's probe is attached to the acupuncture points in 15 minutes.
Probe's temperature is changed 5 cycles from maximum 45℃ to minimum 15℃.
|
The treatment was applied 10 times for 4 weeks.
Most painful 2 points in 8 acupuncture points(both side of Bladder meridian23 (BL23), BL24, BL25, BL26) were used for all the patients assigned to this group.
Autres noms:
|
|
Comparateur factice: Sham heating and cooling therapy
The patients in this group received sham heating and cooling combination therapy in same conditions of treatment group except the temperature.
Before the treatment begin, caregiver measure the patient's skin temperature.
Then probe's temperature is changed 5 cycles from 1℃ over the skin temperature to 1℃ under the skin temperature.
|
The treatment was applied 10 times for 4 weeks.
The sham heating and cooling combination therapy was applied on the 2 of 8 same acupuncture points as in the treatment group.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline in 100mm Pain Visual Analogue Scale (VAS)
Délai: at baseline and 4 4 weeks later from baseline
|
The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'
|
at baseline and 4 4 weeks later from baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline in 100mm Pain Visual Analogue Scale (VAS)
Délai: estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'
|
estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
|
Change from baseline in Korean Oswestry disability index (KODI)
Délai: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
KODI is checked by the patients.
KODI is a questionnaire to measure the back-related disability.
KODI consists of combination of physical and social restriction through 9 questions covering different dimensions of daily living.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Korean Roland Morris Disability Questionnaire (KRMDQ)
Délai: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
KRMDQ is checked by the patients.
KRMDQ is a questionnaire to measure the back-related disability.
KRMDQ consists of 24 questions answered yes or no.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Traditional Medicine Back pain Questionnaire (TMBQ)
Délai: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
TMBQ is checked by the patients.
TMBQ is a questionnaire to measure the back-related disability in aspect of oriental medicine.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Modified schöber test
Délai: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
Modified schöber test measures the flexion range of motion of lumbar spine.
First, investigator marks the point at patients' lumbosacral junction.
Then also marks the points at upper 10cm and lower 5cm of the former point in standing position.
After marking the 3 points, patients bend anteriorly as best he or she can.
Then, investigator measures the length of the latter 2 points.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Finger-to-floor distance
Délai: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
Finger-to-floor distance measures the flexion range of motion of lumbar spine.
Patients stand on the box which height is 20cm.
Then, patients bend anteriorly in extension of knee and upper limb.
Investigator measures the length from floor to 3rd finger.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Change from baseline in Finger-to-thigh distraction
Délai: at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
Finger-to-thigh distraction measures the lateral bending range of motion of lumbar spine.
Patients stand on the box which height is 20cm.
Then, patients bend laterally in extension of knee and upper limb.
Investigator measures the length from floor to 3rd finger.
|
at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment
|
|
Adverse Events
Délai: estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
Any unpredicted symptoms were checked at each follow up visit and if any, the symptom, time of occurrence, and length of duration were recorded and reported.
|
estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Seung Deok Lee, Ph.D., Donnguk University Oriental Medical center
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 septembre 2014
Achèvement primaire (Anticipé)
1 septembre 2015
Achèvement de l'étude (Anticipé)
1 septembre 2015
Dates d'inscription aux études
Première soumission
14 octobre 2014
Première soumission répondant aux critères de contrôle qualité
9 novembre 2014
Première publication (Estimation)
13 novembre 2014
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
13 novembre 2014
Dernière mise à jour soumise répondant aux critères de contrôle qualité
9 novembre 2014
Dernière vérification
1 novembre 2014
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- OCH-S100-2014
- HI11C2135 (Autre subvention/numéro de financement: The Korea Health Industry Development Institute)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .